期刊
EXPERIMENTAL AND MOLECULAR MEDICINE
卷 51, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s12276-019-0235-1
关键词
-
资金
- AHA Predoctoral Fellowship Grant [18PRE33960076]
- National Institute of Health [R01-DK109574, U01-AA021723, R21-AA024636]
- [R01-DK097075]
- [POI-HL114457]
- [R01-HL109233]
- [R01-HL119837]
- [R01-HL133900]
Since the discovery of hypoxia-inducible factor (HIF), numerous studies on the hypoxia signaling pathway have been performed. The role of HIF stabilization during hypoxia has been extended from the induction of a single gene erythropoietin to the upregulation of a couple of hundred downstream targets, which demonstrates the complexity and importance of the HIF signaling pathway. Accordingly, HIF and its downstream targets are emerging as novel therapeutic options to treat various organ injuries. In this review, we discuss the current understanding of HIF signaling in four different organ systems, including the heart, lung, liver, and kidney. We also discuss the divergent roles of HIF in acute and chronic disease conditions and their revealed functions. Finally, we introduce some of the efforts that are being performed to translate our current knowledge in hypoxia signaling to clinical medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据